GLP-1 receptor agonists (GLP-1s) are a class of medications originally developed to treat type 2 diabetes, but theyve also emerged as a transformative option for managing obesity and metabolic syndrome
Rosenstock J, Wysham C, Fras JP, Kaneko S, Lee CJ, Fernndez Land L, Mao H, Cui X, Karanikas CA, Thieu VT
Support quality is hard to verify before you buy, so treat the 24/7 claim as a positioning statement and test it early - send a question through the support channel before you commit, and see how the response lands
As far as the Glow peptide specifically goes, theres a lot of support for GHK-Cu on its own but not much when it comes to the synergistic effects of the glow peptide formula
INFORMATION What is PT-141 (5 mg)
doi: 10.3389/fnagi.2021.687246 61